The Regulatory Catalyst: The Administration for A Healthy America (AHA)

In 2025, the federal government initiated a dramatic restructuring of its health apparatus, consolidating 28 disparate divisions into 15 streamlined units.  At the center of this reorganization is the Administration for a Healthy America (AHA).  This new agency absorbs functions from the CDC, HRSA, and SAMHSA with a singular, high-stakes objective: reversing the chronic disease epidemic by addressing its "root causes".

Under the leadership of Secretary Robert F. Kennedy Jr. and Commissioner Marty Makary, the AHA is moving away from the "medical dogma" of the last half-century.  The agency’s focus has shifted toward metabolic health, environmental exposures, and nutrition.  For the first time, federal policy is not just aimed at "treating" conditions like Type 2 diabetes or hypertension, but at providing the regulatory and financial incentives necessary to "reverse" them.

The Evidence Gap: The Failure of Administrative Proxies

This shift creates a fundamental problem for the current healthcare infrastructure.  For decades, the industry has relied on Administrative Proxies — billing codes and claims data — to measure success.  However, a billing code for "diabetes management" only proves that a service was rendered; it does not prove that the disease was reversed or that the "root cause" was addressed.

As the AHA and CMS move toward Value-Based Contracting that rewards actual disease reversal, the lack of clinical depth in legacy systems has become a "Measurement-toManagement Gap.  "To secure reimbursement in this new era, providers must move beyond "Data Exhaust" and provide Verified Clinical Veracity.

The Circle Solution: Engineering Outcomes at The Node

The Circles platform provides the Regulatory-Grade Governance required to meet the AHA’s mandate.  By defining clinical protocols before the patient encounter, Circles ensure that every data point captured is a reflection of actual clinical change rather than administrative convenience.

Standardized Longitudinal Scores (SLS): Circles capture objective markers — such as metabolic panels, functional movement scores, and patient-reported outcomes — over time.  This allows a clinical node to prove "reversal" with an Audit-Ready "Ground Truth" that federal reviewers can verify.

Outcome Engineering: By moving the focus from "sick care" to "root-cause reversal, "Circles enable clinicians to track the efficacy of interventions like the new 2026 dietary guidelines.  This transforms a standard clinic into a high-veracity research node capable of proving that "food as medicine" actually works.

Surgical-Delay Proof: For surgeons and specialists, this data provides the "Insurable Integrity" needed to justify procedures in an environment where payers are increasingly focused on conservative, root-cause alternatives.

Strategic Outcome: Reclassifying The Enterprise

The AHA reorganization has turned "outcome data" into the most valuable currency in healthcare.  Clinical organizations that continue to rely on fragmented EHR notes will face increasing downward pressure on reimbursement and valuation.

In contrast, organizations that utilize Circles to provide Verified Clinical Veracity are reclassified as Tech-Enabled Assets.  This shift is the primary driver of Multiple Expansion, moving an entity from a 6–8x service multiple to a 12–15x asset multiple.  The valuation of the MSO is no longer tied to the number of patients seen, but to the Insurable Integrity of the reversals it can prove.

Get involved or learn more — contact us today!

If you are interested in contributing to this important initiative or learning more about how you can be involved, please contact us.